Evidence map›Paper›PMID 21846794›Full record

ArticleGenome research2011

Analysis of alternative splicing associated with aging and neurodegeneration in the human brain.

James R Tollervey, Zhen Wang, Tibor Hortobágyi, Joshua T Witten, Kathi Zarnack, Melis Kayikci, Tyson A Clark, Anthony C Schweitzer, Gregor Rot, Tomaž Curk and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Genome research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 151 papers.

0numbers the graph read from it
0cells of the map it votes in
151citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

151 citing papers in PubMed, 253 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. NADScience advances · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

91 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

James R TollerveyMRC Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom.
Zhen Wang
Tibor Hortobágyi
Joshua T Witten
Kathi Zarnack
Melis Kayikci
Tyson A Clark
Anthony C Schweitzer
Gregor Rot
Tomaž Curk
Blaž Zupan
Boris Rogelj
Christopher E Shaw
Jernej Ule
MRC Laboratory of Molecular Biology · GBUniversity of Ljubljana · SIKing's College London · GBEuropean Bioinformatics Institute · GBKing's College - North Carolina · US

Funding

European Research Council 206726Medical Research Council 089701/Z/09/ZMedical Research Council G0500289Medical Research Council G0600676Medical Research Council G0900688Medical Research Council MC_G1000733Wellcome Trust 089701
6 · The paper itself

Abstract

Age is the most important risk factor for neurodegeneration; however, the effects of aging and neurodegeneration on gene expression in the human brain have most often been studied separately. Here, we analyzed changes in transcript levels and alternative splicing in the temporal cortex of individuals of different ages who were cognitively normal, affected by frontotemporal lobar degeneration (FTLD), or affected by Alzheimer's disease (AD). We identified age-related splicing changes in cognitively normal individuals and found that these were present also in 95% of individuals with FTLD or AD, independent of their age. These changes were consistent with increased polypyrimidine tract binding protein (PTB)-dependent splicing activity. We also identified disease-specific splicing changes that were present in individuals with FTLD or AD, but not in cognitively normal individuals. These changes were consistent with the decreased neuro-oncological ventral antigen (NOVA)-dependent splicing regulation, and the decreased nuclear abundance of NOVA proteins. As expected, a dramatic down-regulation of neuronal genes was associated with disease, whereas a modest down-regulation of glial and neuronal genes was associated with aging. Whereas our data indicated that the age-related splicing changes are regulated independently of transcript-level changes, these two regulatory mechanisms affected expression of genes with similar functions, including metabolism and DNA repair. In conclusion, the alternative splicing changes identified in this study provide a new link between aging and neurodegeneration.

Indexed as

AgingAlternative SplicingAdolescentAdultAgedAged, 80 and overAge FactorsAlzheimer DiseaseAntigens, NeoplasmCell Adhesion MoleculesDown-RegulationExonsFrontotemporal Lobar DegenerationGene Expression ProfilingHumansIon ChannelsAntigens, NeoplasmCell Adhesion MoleculesCHL1 protein, humanIon ChannelsNerve Tissue ProteinsNeuro-Oncological Ventral AntigenNRCAM protein, humanPolypyrimidine Tract-Binding ProteinProtein IsoformsRNA-Binding Proteins

Identifiers

PMID21846794
PMCPMC3202275
OpenAlexW2065356080

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.